Sun Pharma Inds.

₹1532.9 1.3 | 0.1%

WEBSITE BSE:524715 NSE : SUN PHARMA. 18 May, 12:50

Market Cap ₹367782 Cr.

Stock P/E 41.3

P/B 14.8

Current Price ₹1532.9

Book Value ₹ 103.2

Face Value 1

52W High ₹1638.7

Dividend Yield 0.75%

52W Low ₹ 922.6

Edit Ratio

Sun Pharma Inds. Research see more...

Overview Inc. Year: 1993Industry: Pharmaceuticals & Drugs

Sun Pharmaceutical Industries Ltd is an multinational pharmaceutical company. The Company is engaged in the business of manufacturing, growing and marketing various generic formulations. It produces a portfolio of generic and speciality medicines concentrated on a spectrum of chronic and acute treatments. The Company's product portfolio consists of generics, branded generics, over-the-counter (OTC)/client healthcare products, speciality, anti-retrovirals (ARVs), active pharmaceutical elements (APIs) and intermediates. Its over the counter brands includes Faringosept , Revital, and Volini. The Company offers its products in types of dosage forms, which includes capsules, pills, sprays, injectables, inhalers, ointments, creams and beverages. Its portfolio of speciality merchandise, branded generics are available in 100 international locations. The Company operates production sites across 6 continents.

Sun Pharma Inds. Share Price

New

Volume

Price

Price: NSE50 DMA200 DMAVolume

Quarterly Price

Quarterly Monthly

Show Value Show %

Peer Comparison

Sun Pharma Inds. Quarterly Results

#(Fig in Cr.)
Net Sales
Other Income
Total Income
Total Expenditure
Operating Profit
Interest
Depreciation
Exceptional Income / Expenses
Profit Before Tax
Provision for Tax
Profit After Tax
Adjustments
Profit After Adjustments
Adjusted Earnings Per Share

Sun Pharma Inds. Profit & Loss

#(Fig in Cr.)	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Net Sales	2432	2829	8028	7733	7684	8982	10303	12532	14116	15586	20812
Other Income	237	178	220	445	690	1252	1286	1511	192	1197	329
Total Income	2669	3007	8249	8178	8374	10234	11589	14043	14308	16783	21141
Total Expenditure	1920	2812	8596	8152	7745	8128	8562	9820	11859	12917	14390
Operating Profit	749	195	-347	26	629	2106	3028	4223	2449	3865	6752
Interest	0	18	551	574	224	388	541	408	268	388	472
Depreciation	86	102	661	464	422	487	553	562	1236	1350	1601
Exceptional Income / Expenses	0	-2876	0	-70	0	-951	-1214	0	-90	-1821	-2938
Profit Before Tax	663	-2801	-1559	-1082	-17	280	719	3253	856	307	1741
Provision for Tax	146	27	-85	5	6	-25	-97	42	13	407	50
Profit After Tax	517	-2829	-1474	-1088	-23	306	817	3211	842	-100	1691
Adjustments	0	0	0	0	0	0	0	0	0	0	0
Profit After Adjustments	517	-2829	-1474	-1088	-23	306	817	3211	842	-100	1691
Adjusted Earnings Per Share	2.5	-13.7	-7.1	-4.5	-0.1	1.3	3.4	13.4	3.5	-0.4	7

Growth Rates

#	1 Year	3 Year	5 Year	10 Year
Sales CAGR	34%	18%	18%	24%
Operating Profit CAGR	75%	17%	26%	25%
PAT CAGR	0%	-19%	41%	13%

#	1 Year	3 Year	5 Year	10 Year
Share Price CAGR	65%	30%	30%	10%
ROE Average	7%	3%	5%	-2%
ROCE Average	7%	4%	6%	0%

Sun Pharma Inds. Balance Sheet

#(Fig in Cr.)	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Shareholder's Funds	7789	7408	22786	21891	21012	22323	22844	24396	26938	24588	23748
Minority's Interest	0	0	0	0	0	0	0	0	0	0	0
Borrowings	5	5	1170	1923	761	1565	1423	1257	5300	4866	7587
Other Non-Current Liabilities	558	2978	3526	2163	1474	684	514	1891	1928	1498	1642
Total Current Liabilities	1155	4233	11052	8627	10963	12558	13272	11204	9951	10106	8365
Total Liabilities	9507	14624	38535	34604	34210	37130	38052	38747	44118	41058	41343
Fixed Assets	1136	1267	3185	3575	4039	4645	4978	5229	9669	9713	8712
Other Non-Current Assets	4483	7658	29899	25713	23783	22910	21904	21577	21719	21641	16166
Total Current Assets	3887	5699	5450	5316	6388	9575	11170	11941	12730	9704	16444
Total Assets	9507	14624	38535	34604	34210	37130	38052	38747	44118	41058	41343

Sun Pharma Inds. Cash Flow

#(Fig in Cr.)	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Opening Cash & Cash Equivalents	169	222	76	121	141	148	98	303	315	351	420
Cash Flow from Operating Activities	106	-2405	149	-1254	-1621	-1171	1242	1306	-417	7636	507
Cash Flow from Investing Activities	461	519	2153	3639	2381	1392	434	1479	1464	-2702	-705
Cash Flow from Financing Activities	-509	1742	-2674	-2368	-753	-272	-1469	-2871	-1000	-4871	169
Net Cash Inflow / Outflow	58	-144	-373	17	7	-52	207	-86	48	63	-29
Closing Cash & Cash Equivalent	222	76	193	138	148	98	303	221	351	420	410

Sun Pharma Inds. Ratios

#	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Earnings Per Share (Rs)	2.49	-13.66	-7.12	-4.52	-0.1	1.27	3.4	13.38	3.51	-0.42	7.05
CEPS(Rs)	2.91	-13.16	-3.93	-2.59	1.66	3.3	5.71	15.72	8.66	5.21	13.72
DPS(Rs)	2.5	1.5	3	1	3.5	2	2.75	4	7.5	10	11.5
Book NAV/Share(Rs)	37.61	35.77	109.74	90.94	87.57	93.04	95.21	101.68	112.28	102.48	98.98
Core EBITDA Margin(%)	20.35	0.58	-6.94	-5.32	-0.78	7.21	14.04	19.6	14.18	16.98	29.5
EBIT Margin(%)	26.34	-95.03	-12.34	-6.46	2.65	5.64	10.16	26.46	7.05	4.42	10.17
Pre Tax Margin(%)	26.33	-95.66	-19.08	-13.76	-0.22	2.36	5.8	23.51	5.37	1.95	8
PAT Margin (%)	20.51	-96.59	-18.05	-13.83	-0.29	2.58	6.58	23.21	5.29	-0.64	7.77
Cash Profit Margin (%)	23.92	-93.11	-9.96	-7.93	5.13	6.68	11.04	27.27	13.06	7.95	15.12
ROA(%)	5.5	-23.44	-5.55	-2.97	-0.07	0.86	2.17	8.36	2.03	-0.23	4.1
ROE(%)	6.59	-37.23	-9.78	-4.88	-0.11	1.41	3.62	13.6	3.28	-0.39	7
ROCE(%)	8.42	-31.53	-5.11	-1.77	0.75	2.38	4.31	12.19	3.46	2.19	7.28
Receivable days	105.15	107.05	62.18	88.2	110.36	122.88	151.6	147.72	146.18	125.78	95.31
Inventory Days	109.34	111.38	69.43	100.29	103.99	68.38	72.52	71.57	69.43	79.29	61.97
Payable days	179.16	154.28	114.01	203.22	213.15	238.64	234.55	171.17	220.03	217.66	175.92
PER(x)	164.07	0	0	0	0	388.88	140.81	26.32	170.21	0	139.51
Price/Book(x)	10.88	16.03	9.32	9.01	7.85	5.32	5.03	3.46	5.32	8.93	9.93
Dividend Yield(%)	0.31	0.26	0.29	0.12	0.51	0.4	0.57	1.14	1.26	1.09	1.17
EV/Net Sales(x)	34.69	42.78	27.17	26.23	22.24	13.98	11.75	7.2	10.64	14.36	11.68
EV/Core EBITDA(x)	112.59	621.16	-628.52	7678.6	271.64	59.63	39.99	21.37	61.31	57.9	36
Net Sales Growth(%)	-39.43	16.31	183.81	-3.68	-0.64	16.9	14.7	21.63	12.64	10.41	33.53
EBIT Growth(%)	-61.57	-519.42	63.79	49.59	140.71	223.34	88.52	190.47	-69.32	-38.12	218.47
PAT Growth(%)	-69.57	-647.58	47.88	26.23	97.9	1438.18	167.18	293.23	-73.77	-111.87	1790.89
EPS Growth(%)	-69.57	-647.59	47.88	36.51	97.89	1438.13	167.17	293.23	-73.77	-111.87	1791.07
Debt/Equity(x)	0.01	0.33	0.3	0.27	0.29	0.31	0.28	0.26	0.26	0.2	0.32
Current Ratio(x)	3.37	1.35	0.49	0.62	0.58	0.76	0.84	1.07	1.28	0.96	1.97
Quick Ratio(x)	2.61	1.13	0.3	0.37	0.37	0.59	0.63	0.83	0.94	0.62	1.49
Interest Cover(x)	1507.89	-151.4	-1.83	-0.88	0.92	1.72	2.33	8.97	4.2	1.79	4.69
Total Debt/Mcap(x)	0	0.02	0.03	0.03	0.04	0.06	0.06	0.08	0.05	0.02	0.03

Sun Pharma Inds. Shareholding Pattern

#	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	54.48	54.48	54.48	54.48	54.48	54.48	54.48	54.48	54.48	54.48
FII	13	14.44	14.95	15.99	16.87	16.89	16.48	16.79	17.07	17.72
DII	21	20.02	19.66	19.64	19.14	19.24	19.75	19.67	19.52	18.82
Public	11.53	11.06	10.91	9.89	9.52	9.39	9.29	9.07	8.92	8.97
Others	0	0	0	0	0	0	0	0	0	0
Total	100	100	100	100	100	100	100	100	100	100

#	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	130.71	130.71	130.71	130.71	130.71	130.71	130.71	130.71	130.71	130.71
FII	31.18	34.64	35.86	38.37	40.47	40.52	39.54	40.28	40.97	42.52
DII	50.38	48.03	47.17	47.13	45.92	46.17	47.39	47.19	46.84	45.17
Public	27.66	26.55	26.19	23.72	22.84	22.52	22.29	21.75	21.41	21.53
Others	0	0	0	0	0	0	0	0	0	0
Total	239.93	239.93	239.93	239.93	239.93	239.93	239.93	239.93	239.93	239.93

Pros

Company has delivered good profit growth of 40% CAGR over last 5 years
Debtor days have improved from 217.66 to 175.92days.
Company is almost debt free.

Cons

Company has a low return on equity of 3% over the last 3 years.
Stock is trading at 14.8 times its book value.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Sun Pharma Inds. News

IPO

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Sun Pharma Inds.

Add Watchlist

Sun Pharma Inds. Research see more...

Overview Inc. Year: 1993Industry: Pharmaceuticals & Drugs

Sun Pharma Inds. Share Price

Alert Data

Quarterly Price

Peer Comparison

Sun Pharma Inds. Quarterly Results

Sun Pharma Inds. Profit & Loss

Growth Rates

Sun Pharma Inds. Balance Sheet

Sun Pharma Inds. Cash Flow

Sun Pharma Inds. Ratios

Sun Pharma Inds. Shareholding Pattern

Sun Pharma Inds. News

IPO

Stocx: India's #1 Marketplace to Find Your Winning Stock

Please Login!

Error!